158 related articles for article (PubMed ID: 2246554)
21. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
22. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.
Landgren O; Gridley G; Turesson I; Caporaso NE; Goldin LR; Baris D; Fears TR; Hoover RN; Linet MS
Blood; 2006 Feb; 107(3):904-6. PubMed ID: 16210333
[TBL] [Abstract][Full Text] [Related]
23. Identifying monoclonal gammopathy of undetermined significance in electronic health data.
Epstein MM; Saphirak C; Zhou Y; LeBlanc C; Rosmarin AG; Ash A; Singh S; Fisher K; Birmann BM; Gurwitz JH
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):69-76. PubMed ID: 31736189
[TBL] [Abstract][Full Text] [Related]
24. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.
Cohen HJ; Crawford J; Rao MK; Pieper CF; Currie MS
Am J Med; 1998 May; 104(5):439-44. PubMed ID: 9626026
[TBL] [Abstract][Full Text] [Related]
25. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
Castaneda-Avila MA; Ulbricht CM; Epstein MM
Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
28. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology of monoclonal gammopathies].
Hurez D
Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
[TBL] [Abstract][Full Text] [Related]
31. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
[TBL] [Abstract][Full Text] [Related]
32. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
Cohen AL; Sarid R
Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
[TBL] [Abstract][Full Text] [Related]
34. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
35. Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance.
Castañeda-Avila MA; Lapane KL; Person SD; Jesdale BM; Zhou Y; Mazor KM; Epstein MM
Cancer Control; 2022; 29():10732748221126936. PubMed ID: 36112886
[TBL] [Abstract][Full Text] [Related]
36. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
38. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition.
Therneau TM; Kyle RA; Melton LJ; Larson DR; Benson JT; Colby CL; Dispenzieri A; Kumar S; Katzmann JA; Cerhan JR; Rajkumar SV
Mayo Clin Proc; 2012 Nov; 87(11):1071-9. PubMed ID: 22883742
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.
Neriishi K; Nakashima E; Suzuki G
Br J Haematol; 2003 May; 121(3):405-10. PubMed ID: 12716362
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
Iwanaga M; Tomonaga M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
